Sao Paulo, Jan 25 (IANS/EFE) Researchers at the University of Brasilia (UnB) and Brazil's state-owned agriculture and livestock research company Embrapa have discovered a protein in coffee with effects similar to morphine.
Embrapa's genetics and biotechnology resources division and the UnB successfully "identified previously unknown fragments of protein -- peptides -- in coffee that have an effect similar to morphine, in other words they have an analgesic and sedative activity," a statement from Embrapa said Saturday.
Those peptides, it said, "have a positive differential: their effects last longer in experiments with laboratory mice".
The two institutions applied for patents to Brazilian regulators for the seven "opioid peptides" identified in the study.
The discovery of the molecules came about through the doctorate research work of Felipe Vinecky of the molecular biology department at UnB, who with the consultation of Embrapa was looking to combine coffee genes to improve the quality of the grain.
The study was also supported by France's Centre for International Cooperation on Agricultural Research and Development, or CIRAD.
--IANS/EFE
vr/bg
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
